ID Source | ID |
---|---|
PubMed CID | 166350 |
MeSH ID | M0081535 |
Synonym |
---|
qmdp 66 |
quinonyl-mdp-66 |
72921-52-9 |
[(2r,3s,4r,5r,6s)-5-acetamido-4-[1-[[(2s)-1-[[(2r)-5-amino-1-methoxy-1,5-dioxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]oxy-3,6-dihydroxyoxan-2-yl]methyl 10-(4,5-dimethoxy-2-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)decanoate |
quinonyl-n-acmu-val-iso-gln-methyl ester |
d-alpha-glutamine, n2-(n-(n-acetyl-6-o-(10-(4,5-dimethoxy-2-methyl-3,6-dioxo-1,4-cyclohexadien-1-yl)-1-oxodecyl)muramoyl)-l-valyl)-, methyl ester |
quinonyl-n-acetylmuramyl-l-valyl-d-isoglutamine methyl ester |
quinonyl-n-acetylmuramyldipeptide |
DTXSID60993702 |
2-deoxy-6-o-[10-(4,5-dimethoxy-2-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)decanoyl]-2-[(1-hydroxyethylidene)amino]-3-o-[1-hydroxy-1-({1-hydroxy-1-[(5-hydroxy-5-imino-1-methoxy-1-oxopentan-2-yl)imino]-3-methylbutan-2-yl}imino)propan-2-yl]hexopyranose |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 9 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.15) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (11.11%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (88.89%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |